Skip to content

Optical Imaging of Retinal Vascular Metrics Under Different Dietary Conditions

Optical Imaging of Retinal Vascular Metrics Under Different Dietary Conditions

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07818239
Enrollment
10
Registered
2026-09-14
Start date
2026-09-01
Completion date
2027-09-01
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Brief summary

In a typical clinical setting, patient eating habits are not controlled when performing optical coherence tomography (OCT) imaging for retinal diagnostics. Nevertheless, the timing of the patient's most recent meal has the potential to impact OCT metrics particularly for those involving blood vessels, such as vascular density. Studies have shown that eating a high fat meal can increase blood fat levels in the hours following the meal. In particular, chylomicrons, the fat particles that will most likely affect the OCT signal, peak in concentration about 2-3 hours after eating. Preclinical animal studies have shown that intravascular injections of fat emulsions in rodent models can cause an increase in OCT signal and make blood vessels more visible. This study investigates the impact of a single high fat meal on OCT and OCT angiography (OCTA) measurements of retinal vessels and whether these effects differ from the effects of a single low-fat, high carbohydrate meal.

Interventions

OTHERConsumption of a high fat meal

Consumption of a high fat meal: Volume 500ml, Lipid 80 % of calories

OTHERConsumption of a high carbohydrate meal

Consumption of a high carbohydrate meal: Volume 500ml, Carbohydrate 80% of calories

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Crossover study design, two separate Arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men and women aged over 18 years * Signed informed consent * Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant * Normal ophthalmic findings

Exclusion criteria

* Symptoms of a clinically relevant illness in the 3 weeks before the first study day * Presence or history of a severe medical condition as judged by the clinical investigator * Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study (except hormonal contraceptives) * Untreated arterial hypertension (defined as either systolic blood pressure \>150 mmHg or diastolic blood pressure \>95 mmHg) * Blood donation during the previous three weeks * Presence of any abnormalities preventing reliable measurements in the study eye as judged by the investigator * Pregnancy, planned pregnancy or lactating * Lactose intolerance or other relevant food allergy or sensitivity

Design outcomes

Primary

MeasureTime frameDescription
Retinal vessel area density (OCTA)On both study days, from the start of the meal consumption every 30 min up to 5 hours after meal consumption; BL, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300minRetinal vessel area density measured by OCTA

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026